Overview

Study With a Topical Gel to Treat Common Warts in Adults

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The primary purpose of this study is to evaluate the effectiveness in adults of four different strengths of resiquimod gel applied to common wart(s) five times a week for four weeks. A second purpose is to evaluate the safety of the drug.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Graceway Pharmaceuticals, LLC
Criteria
Inclusion Criteria:

- Diagnosis of common warts

- Two forms of birth control

Exclusion Criteria:

- Pregnant or breast feeding

- Other types of warts, ie. plantar

- Currently participating in another clinical study

- Chronic viral hepatitis B or C